TGILR and breast carcinoma: Consistently, chip-seq analysis regarding SMAD3 in lung cancer (NCL-H441) and breast cancer cell lines (HCC1954, MDA-MB-231) together showed that there were 3 SMAD3 binding peaks in the promoter region of TGILR (Fig. 2h).